关于"2025年ESC/EAS失脂症指导方针的重点更新:加强预防,风险分层和治疗"
Akshyaya Pradhan1, Prashant Thandi1, Kunal Mahajan2
1Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India, 226003.
The American journal of cardiology
|March 5, 2026
概括
2025年ESC/EAS脂质指南更新引入了SCORE2/SCORE2-OP,以更好地评估动脉样硬化心血管疾病 (ASCVD) 的风险. 它强调对高风险个体进行强化降脂疗法,改善心血管疾病的预防.
科学领域:
- 心脏病学 心脏病学
- 动脉样硬化研究 动脉样硬化研究
- 预防医学 预防医学
背景情况:
- 失脂症是动脉样硬化心血管疾病 (ASCVD) 的一个关键可修改的风险因素.
- 以前的风险评估工具需要更新,以反映当前的证据和治疗进展.
- 欧洲心脏病学会和欧洲动脉样硬化学会 (ESC/EAS) 提供了脂质管理的指南.
研究的目的:
- 提出2025年针对性更新的ESC/EAS指南,用于管理脂质疾病.
- 概述心血管疾病 (CVD) 风险评估和新型治疗策略的进展.
- 为优化CVD预防中的脂质管理提供基于证据的建议.
主要方法:
- 从SCORE系统过渡到SCORE2和SCORE2-OP风险模型,用于10年ASCVD风险估计.
- 在风险计算中包括致命和非致命的心血管事件,将年龄范围扩大到89.
- 重新校准国家特定的风险集群,并优先考虑非高密度胆固醇而不是总胆固醇.
主要成果:
- SCORE2和SCORE2-OP模型提供了更广泛的适用性和更精确的风险分层.
- 根据最新的临床试验数据,强调针对高风险个体进行强化降脂疗法.
- 更新的指南与2019年标准对比建议,详细说明了初级和二级预防的新策略.
结论:
- 2025年ESC/EAS指南代表了心血管疾病预防策略的重大演变.
- 预计这些指导方针的实施将进一步减少ASCVD事件.
- 这些指导方针是临床医生和研究人员在管理脂质疾病和心血管风险方面的重要工具.
相关概念视频
01:26Atherosclerosis III: Management
538
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:26Coronary Artery Disease IV: Preventive Measures
786
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
01:30Atherosclerosis I: Introduction
1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
01:26Angina IV: Management
368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
01:27Peripheral Artery Disease III: Interprofessional Care
465
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465